Rho Ventures: Portfolio: Healthcare

Healthcare/Information Technology



Name: Sector: Chief Executive:		NephroGenex Healthcare J. Wesley Fox, PhD

Summary:		Clinical stage biotechnology company focused on kidney disease.

Stage of Initial Investment:		Venture
Liquidity:		Private